search
Back to results

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

Primary Purpose

Urinary Calculi, Percutaneous Nephrolithotomy

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Without reverse insertion of a ureteral catheter
Sponsored by
The First Affiliated Hospital of University of South China
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Urinary Calculi focused on measuring Ureteral catheter, Without reverse insertion, Percutaneous nephrolithotomy, Tubeless, Urinary calculi

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Participants who met the the applications of PCNL surgery in the 2019 Chinese Guidelines for the Diagnosis and Treatment of Urological Diseases
  • Participants who agree to undergo tubeless PCNL
  • The participants' maximum diameter of the stone should be less than 3.5cm

Exclusion Criteria:

  • Confirmation by computerized tomography (CT) images and blood biochemical indicators of infectious stones or complex staghorn stones
  • Obvious surgical contraindications, such as severe heart and lung insufficiency, abnormal coagulatory function
  • Previous PCNL or nephrolithotomy, presence of an indwelling ureteral stent or nephrostomy tube before surgery
  • Renal trauma or congenital malformation of the urinary system

Sites / Locations

  • The First Affiliated Hospital of University of South ChinaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental group(group 1)

Control group(group 2)

Arm Description

Without reverse insertion of a ureteral catheter in tubeless percutaneous nephrolithotomy.

Traditional tubeless percutaneous nephrolithotomy need reverse insert a ureteral catheter.

Outcomes

Primary Outcome Measures

Changes of inflammatory indicators after surgery
Pre- vs. post-operative blood leukocyte counts and neutrophil-ratio difference
Changes in renal bleeding after surgery
Pre- vs. post-operative difference in hemoglobin and hematocrit values
Changes of renal-function after surgery
Preoperative and postoperative blood creatinine difference
Pain score after surgery
According to the Visual Analogue Scale(VAS) to evaluate the score. Scores range from 0 to 10, where 0 represents no pain and 10 represents the highest pain.
Incidence of pneumothorax and hydrothorax
The rate of pneumothorax and hydrothorax after surgery
Incidence of ureteral stone street
The rate of ureteral stone street after surgery

Secondary Outcome Measures

Duration of operation
From the completion of anesthesia to the end of the suture incision.
Duration of hospital stay
From the date of admission to the date of discharge.
Hospital costs
The cost from hospitalization to discharge.
Stone-free rates
Preoperative and postoperative stone dimensions are compared by radiological assessment. Postoperative residual calculi < 4 mm in diameter reflect complete removal of calculi (stone-free rate = 100%).

Full Information

First Posted
October 1, 2022
Last Updated
May 14, 2023
Sponsor
The First Affiliated Hospital of University of South China
search

1. Study Identification

Unique Protocol Identification Number
NCT05574517
Brief Title
Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter
Official Title
A Comparative Study of Tubeless Percutaneous Nephrolithotomy With or Without Reverse Ureteral Catheter Insertion
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 7, 2022 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The First Affiliated Hospital of University of South China

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi. The advent of tubeless PCNL (without indwelling nephrostomy tube) has been proved to be safe and effective in reducing postoperative discomfort, shortening hospitalization time and reducing hospitalization costs. Traditional tubeless PCNL usually involves retrograde insertion of the ureteral catheter, which may cause many ureteral related surgical complications. However, there are few reports on tubeless PCNL without reverse ureteral catheter insertion. The goal of this study is to explore the safety and effectiveness of the tubeless PCNL without reverse ureteral catheter insertion.
Detailed Description
This is a key clinical research project of the University of South China (No. USCKF201902K01). The goal of this study is to comparative the safety and clinical efficacy between the tubeless percutaneous nephrolithotomy without reverse insertion of a ureteral catheter and the traditional tubeless percutaneous nephrolithotomy with reverse insertion of a ureteral catheter in the treatment of upper urinary calculi, and to explore the former' applications. It is a prospective, randomized controlled single center study that is conducted for 2 years anticipatively. The clinic physician is responsible for patient recruitment and allocation and the application of computerized random-number generation. For random allocation, participants are given random numbers. Participants with odd numbers are assigned to experimental group, where they undergo tubeless PCNL without reverse insertion of a ureteral catheter. Participants with even numbers are assigned to control group and undergo tubeless PCNL with reverse insertion of a ureteral catheter. The doctors managing the operations accept participants and execute the surgical treatments. All participants sign clinical-trial informed consent and surgical informed consent during the preoperative conversation. Follow-up observation is conducted for 1 month after surgery. After completion of the study, we collect relevant clinical data from the participants. The primary and secondary outcomes are analyzed and compared between the two groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Calculi, Percutaneous Nephrolithotomy
Keywords
Ureteral catheter, Without reverse insertion, Percutaneous nephrolithotomy, Tubeless, Urinary calculi

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants are randomly assigned to an experimental or control group in parallel.
Masking
Participant
Masking Description
A single-blind trial in which participants were unaware of the study group and the intervention.
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental group(group 1)
Arm Type
Experimental
Arm Description
Without reverse insertion of a ureteral catheter in tubeless percutaneous nephrolithotomy.
Arm Title
Control group(group 2)
Arm Type
No Intervention
Arm Description
Traditional tubeless percutaneous nephrolithotomy need reverse insert a ureteral catheter.
Intervention Type
Procedure
Intervention Name(s)
Without reverse insertion of a ureteral catheter
Intervention Description
Traditional tubeless percutaneous nephrolithotomy usually need retrograde ureteral catheter insertion. Our intervention is that the tubeless percutaneous nephrolithotomy is executed without reverse insertion of a ureteral catheter.
Primary Outcome Measure Information:
Title
Changes of inflammatory indicators after surgery
Description
Pre- vs. post-operative blood leukocyte counts and neutrophil-ratio difference
Time Frame
Hour 3 after the surgery
Title
Changes in renal bleeding after surgery
Description
Pre- vs. post-operative difference in hemoglobin and hematocrit values
Time Frame
Hour 3 after the surgery
Title
Changes of renal-function after surgery
Description
Preoperative and postoperative blood creatinine difference
Time Frame
Hour 3 after the surgery
Title
Pain score after surgery
Description
According to the Visual Analogue Scale(VAS) to evaluate the score. Scores range from 0 to 10, where 0 represents no pain and 10 represents the highest pain.
Time Frame
Hour 3 after the surgery
Title
Incidence of pneumothorax and hydrothorax
Description
The rate of pneumothorax and hydrothorax after surgery
Time Frame
Day 2 after the surgery
Title
Incidence of ureteral stone street
Description
The rate of ureteral stone street after surgery
Time Frame
Day 2 after the surgery
Secondary Outcome Measure Information:
Title
Duration of operation
Description
From the completion of anesthesia to the end of the suture incision.
Time Frame
during the procedure
Title
Duration of hospital stay
Description
From the date of admission to the date of discharge.
Time Frame
immediately after the discharge
Title
Hospital costs
Description
The cost from hospitalization to discharge.
Time Frame
immediately after the discharge
Title
Stone-free rates
Description
Preoperative and postoperative stone dimensions are compared by radiological assessment. Postoperative residual calculi < 4 mm in diameter reflect complete removal of calculi (stone-free rate = 100%).
Time Frame
Day 2 after the surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participants who met the the applications of PCNL surgery in the 2019 Chinese Guidelines for the Diagnosis and Treatment of Urological Diseases Participants who agree to undergo tubeless PCNL The participants' maximum diameter of the stone should be less than 3.5cm Exclusion Criteria: Confirmation by computerized tomography (CT) images and blood biochemical indicators of infectious stones or complex staghorn stones Obvious surgical contraindications, such as severe heart and lung insufficiency, abnormal coagulatory function Previous PCNL or nephrolithotomy, presence of an indwelling ureteral stent or nephrostomy tube before surgery Renal trauma or congenital malformation of the urinary system
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mingyong Li, MD
Phone
18175878363
Email
myli1123@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mingyong Li, MD
Organizational Affiliation
The First Affiliated Hospital of University of South China
Official's Role
Principal Investigator
Facility Information:
Facility Name
The First Affiliated Hospital of University of South China
City
Hengyang
State/Province
Hunan
ZIP/Postal Code
421001
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mingyong LI
Phone
18175878363
Email
myli1123@126.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All individual participant data that underlie results in a publication.
IPD Sharing Time Frame
Starting 1 year after publication.
IPD Sharing Access Criteria
When proper editing or review requirements are met, the study data will be available from the study manager after the study is completed.

Learn more about this trial

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

We'll reach out to this number within 24 hrs